Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: coment

  1. Aomar-Millán, I.F.
  2. Salvatierra, J.
  3. Callejas-Rubio, J.L.
  4. Raya-Álvarez, E.
Revue:
Reumatologia Clinica

ISSN: 1885-1398,  1699-258X

Année de publication: 2023

Volumen: 19

Número: 2

Pages: 120-121

Type: Lettre

DOI: 10.1016/J.REUMA.2022.01.003 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus